M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
Clinical trial NCT01621243 · TERMINATED
Trial details
- NCT number
- NCT01621243
- Sponsor
- Momenta Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2016-10-24
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.